USP site in China
This article was originally published in The Tan Sheet
Executive Summary
U.S. Pharmacopeia's newest international site in Shanghai will enable the organization to work with Chinese regulators and manufacturers to ensure the safety of dietary supplements, pharmaceuticals and food ingredients, USP states in a Sept. 6 release. The opening of the site was celebrated with a ribbon-cutting ceremony Sept. 8, which was attended by USP executives as well as State Food and Drug Administration officials, among others. "USP-China will work closely with SFDA, the Chinese Pharmacopeia Commission, [the National Institute for the control of Pharmaceutical and Biological Products] and other constituencies to help ensure the quality of medicines and food ingredients," USP says. "Our presence will benefit Chinese manufacturers, government agencies and ultimately patients in China, U.S. and the many countries to which China exports," organization adds. SFDA recently announced it was planning to spend 8.8 bil. yuan ($1.1 bil.) over the next three to five years to strengthen food and drug oversight and infrastructure (1"The Tan Sheet" Aug. 27, 2007, In Brief)...